S 974 115th Congress Senate Health Civil actions and liability Drug safety, medical device, and laboratory regulation Licensing and registrations Prescription drugs Product development and innovation

CREATES Act of 2017

Introduced: April 27, 2017 See on congress.gov

Everywhere this bill has been 5 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jun 21, 2018

Placed on Senate Legislative Calendar under General Orders. Calendar No. 482.

Jun 21, 2018

Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.

Jun 14, 2018

Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.

Apr 27, 2017

Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S2619)

Apr 27, 2017

Introduced in Senate

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Plain-English summary Congressional Research Service

Creating and Restoring Equal Access To Equivalent Samples Act of 2017 or the CREATES Act of 2017

This bill permits the developer of a drug or biological product to bring a civil action against the license holder of an approved drug or biological product if the holder has declined to make available sufficient quantities of the approved drug or product for the developer's testing.

What's happening now June 21, 2018

Placed on Senate Legislative Calendar under General Orders. Calendar No. 482.

Related & companion bills 1

Bill text 2 versions